Across Kyrgyzstan, many patients are facing deadly delays in treatment due to a worsening shortage of life-saving medicines. Women like Almagul Ibrayeva, a breast cancer survivor, say they are struggling to find essential drugs. After her surgery, she depends on hormone therapy to stay alive but often has to rely on family abroad to send her medicine.
The supply of medicine in Kyrgyzstan remains low and unreliable. Patients often turn to foreign sources or black markets, risking expired or fake drugs. One woman said she only received government-provided anti-cancer medicine three times in seven years. Many families sell livestock or fall into debt just to afford proper treatment. For many, survival now depends on luck and connections, not the healthcare system.
Although the government has launched Kyrgyz Pharmacy to improve supply and reduce prices, progress remains slow. Promises have been made, but patients continue to wait months for medicine. Meanwhile, thousands of health professionals are still missing from hospitals, worsening the crisis. The recent push to meet Eurasian Economic Union standards may also cause 6,000 medicines to disappear from shelves by 2026.
Community-led efforts are trying to fill the gaps. Cancer survivor Shairbu Saguynbayeva founded a support center in Bishkek that provides shelter and help for women during treatment. Women there sew and sell traditional crafts to fund therapies for others. Despite these efforts, demand continues to outpace resources, leaving patients in fear.
Doctors urge early detection as one of the few ways to reduce treatment costs and save lives. Still, the most vulnerable continue to suffer. One mother of three reportedly died because she didn’t receive her medicine on time. As one activist put it: “It is better to save a mother than to build orphanages.”